EP Patent

EP3154549A1 — Method of treating non-small cell lung cancer and/or small cell lung cancer using thienotriazolodiazepine compounds

Assigned to Oncoethix GmbH · Expires 2017-04-19 · 9y expired

What this patent protects

A method of treating non-small cell lung cancer and/or small cell lung cancer in a mammal comprises the step of administering to a patient a pharmaceutical acceptable amount of a compound being a thienotriazolodiazepine compound of the Formula (1).

USPTO Abstract

A method of treating non-small cell lung cancer and/or small cell lung cancer in a mammal comprises the step of administering to a patient a pharmaceutical acceptable amount of a compound being a thienotriazolodiazepine compound of the Formula (1).

Drugs covered by this patent

Patent Metadata

Patent number
EP3154549A1
Jurisdiction
EP
Classification
—
Expires
2017-04-19
Drug substance claim
No
Drug product claim
No
Assignee
Oncoethix GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.